In this episode we discuss:
- How GLP-1 medications work and why they suppress appetite
- The most common digestive side effects and how to manage them
- Why reduced food intake can lead to significant nutrient deficiencies
- How rapid weight loss can contribute to muscle loss and reduced bone density
- Why protein and resistance training are essential during GLP-1 therapy
- What the research says about creatine and muscle preservation
- What causes Ozempic face, loose skin, and hair shedding
- Why weight regain is common after discontinuing GLP-1 medications
- How to develop sustainable nutrition and exercise habits for long-term health
Show notes:
- “Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: The SURMOUNT-4 randomized clinical trial” by Aronne, L. J., et al.
- “Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity” by Blundell, J., et al.
- “Nutritional deficiencies and muscle loss in adults with type 2 diabetes using GLP-1 receptor agonists: A retrospective observational study” by Butsch, W. S., et al.
- “Effect of creatine supplementation during resistance training on lean tissue mass and muscular strength in older adults: A meta-analysis” by Chilibeck, P. D., et al.
- “The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity” by Friedrichsen, M., et al.
- “Effects of GLP-1 analogues and agonists on the gut microbiota: A systematic review” by Gofron, K. K., Wasilewski, A., & Małgorzewicz, S.
- “Oral hyaluronan relieves wrinkles and improves dry skin: A 12-week double-blinded, placebo-controlled study” by Hsu, T.-F., et al.
- “Implications of Ozempic and other semaglutide medications for facial plastic surgeons” by Humphrey, C. D., & Lawrence, A. C.
- “Bone health after exercise alone, GLP-1 receptor agonist treatment, or combination treatment: A secondary analysis of a randomized clinical trial” by Jensen, S. B. K., et al.
- “Investigating nutrient intake during use of glucagon-like peptide-1 receptor agonist: A cross-sectional study” by Johnson, B., et al.
- “Overall skin tone and skin-lightening-improving effects with oral supplementation of lutein and zeaxanthin isomers: A double-blind, placebo-controlled clinical trial” by Juturu, V., et al.
- “Higher compared with lower dietary protein during an energy deficit combined with intense exercise promotes greater lean mass gain and fat mass loss: A randomized trial” by Longland, T. M., et al.
- “Healthy weight loss maintenance with exercise, liraglutide, or both combined” by Lundgren, J. R., et al.
- “The effects of Bacillus coagulans MTCC 5856 on functional gas and bloating in adults: A randomized, double-blind, placebo-controlled study” by Majeed, M., et al.
- “Efficacy and safety of glucagon-like peptide-1 receptor agonists for weight loss among adults without diabetes: A systematic review of randomized controlled trials” by Moiz, A., et al.
- “A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults” by Morton, R. W., et al.
- “Nutritional priorities to support GLP-1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society” by Mozaffarian, D., et al.
- “Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies” by Neeland, I. J., Linge, J., & Birkenfeld, A. L.
- “GLP-1RA and the possible skin aging” by Paschou, I. A., et al.
- “The roles of vitamin C in skin health” by Pullar, J. M., Carr, A. C., & Vissers, M. C. M.
- “Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists among US adults with overweight or obesity” by Rodriguez, P. J., et al.
- “Alopecia as an emerging adverse effect associated with glucagon-like peptide-1 (GLP-1) receptor agonists for weight loss: A scoping review” by Rojas Lopez, R. F., et al.
- “The efficacy and safety of GLP-1 RAs in the modification of cardiovascular morbidity in patients with obesity without diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials involving 32,884 patients” by Tanashat, M., et al.
- “Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension” by Wilding, J. P. H., et al.
- Learn more about Adapt Naturals Bio-Avail Multi, Biome Protect, Inner Radiance, or take our quiz to see which products best suit your needs
- If you’d like to ask a question for Chris to answer in a future episode, submit it here
- Follow Chris on Instagram or Facebook
Hey everybody, Chris Kresser here. Welcome to another episode of Revolution Health Radio. Today we’re going to talk about GLP-1 medications again. I don’t think I need to explain what these are. Everybody has heard of them, or is taking them, or knows someone that’s taking them. These are the class of drugs that include semaglutide, sold as Ozempic and Wegovy, tirzepatide, which is sold as Munjaro and Zepbound, and some other newer medications in the pipeline.
So you probably noticed the public conversation swings between two extremes: either these drugs are a miracle that will end obesity and make everyone live happily ever after, or they’re a dangerous shortcut that people should be embarrassed to use. And I don’t find either position useful. GLP-1s are powerful drugs, and for a lot of people, they produce weight loss and metabolic improvements that years of dieting never did. They also come with real costs that many people aren’t told about when they get the prescription. Both of these things are true, and the second one is what this episode’s about.
GLP-1 drugs for weight loss weren’t part of my clinical practice. They weren’t available when I was practicing, at least not to the extent that they are now, so I didn’t manage many patients on them. What I’m sharing today comes from the research, along with what I’ve learned over 15 years of working with people on digestive problems, nutrient deficiencies, and muscle and bone loss, which happens to be the main problems that show up on these medications.
Much of what I’ll cover comes from a 2025 joint advisory from four organizations: the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society. It named the main challenges of GLP-1 therapy in plain terms: GI side effects, nutritional deficiencies caused by eating less, muscle and bone loss, and low long-term adherence followed by weight regain. It called nutritional management of the GI side effects “critical” and recommended resistance training and an appropriate diet to preserve muscle and bone. These are mainstream medical and nutrition societies, not supplement companies or wellness influencers.
For many people, though, the prescription is the only guidance they get. They leave with a pen and a dosing schedule and have to figure out the rest on their own. By the end of this episode, you’ll understand why these side effects happen and how common they are, and you’ll have specific diet, exercise, and lifestyle strategies for each one. I’ll also share the supplements I think are worth considering, and I’ll be clear about what the evidence does and doesn’t show for them. Let’s dive in.
Okay, let’s start with how these drugs work, because nearly every side effect comes from the same two mechanisms. GLP-1 is a hormone your gut releases after you eat. It signals your brain that you’ve had enough, and it slows the rate at which your stomach empties into your small intestine. The medications mimic this hormone, but they act far more strongly and last far longer than the version your body makes. Terzapatide also acts on a second gut hormone called GIP. The effect on appetite is enormous. In a 2021 trial in Diabetes, Obesity, and Metabolism, people taking semaglutide ate 35 percent less at an all-you-can-eat lunch than people taking placebo. An earlier study at a lower dose found people ate 24 percent less across all the meals it measured. The effect on stomach emptying seems to fade with continued use. In that same 2021 trial, the researchers found no evidence of delayed stomach emptying by week 20, which may help explain why GI symptoms do ease after the first few months, at least for most people. Eating less is how the drugs produce weight loss, and it’s also the source of most of the problems we’ll cover. A quarter to a third less food means a quarter to a third less protein, fiber, vitamins, minerals, and phytonutrients unless you plan carefully. Slower stomach emptying is behind the nausea, early fullness, and reflux many people get. Fast weight loss also takes muscle along with fat.
So digestive side effects are the most common problem. They’re usually the one that people notice first. A 2025 systematic review looked at 26 randomized trials of GLP-1 drugs for weight loss in people without diabetes. Gastrointestinal side effects occurred in 47 to 84 percent of people taking the drugs, compared with 13 to 63 percent of people on placebo, and the most common were nausea, vomiting, diarrhea, and constipation. A separate 2025 meta-analysis of 19 trials found people on GLP-1s were almost four times as likely to vomit and more than twice as likely to have nausea or constipation as people on placebo. For many, these symptoms are mild and fade within the first few months, especially once the dose stops going up. But for others, they don’t, and that has consequences beyond discomfort.
A 2025 study in JAMA Network Open followed more than 125,000 people who started on GLP-1 drugs. Within a year, about 65 percent of those without type 2 diabetes had stopped taking it, along with about 47 percent of those with diabetes. People who had moderate or severe GI side effects were the most likely to stop. In the 2022 extension of the STEP 1 trial, people who stopped semaglutide regained about two-thirds of the weight they’d lost within a year, and most of their improvements in blood sugar, blood pressure, and cholesterol drifted back toward where they started. In SURMOUNT-4, a 2024 trial of tirzepatide in JAMA, people switched to placebo regained 14 percent of their body weight over the following year, while those who were maintained on the drug continue to lose weight. If GI side effects push you to quit the medication, you’re likely to regain much of what you lost.
Several things can help here: eat smaller meals, and stop when you feel satisfied rather than full, because your stomach is emptying more slowly than it used to and the signal you’re full arrives late. Go easy on greasy, fried, and rich foods, since fat slows stomach emptying even further and tends to make nausea worse. Of course, this is a good recommendation in general, especially if these foods are cooked in bad oils. If reflux is an issue, finish eating at least a few hours before bed and avoid lying down right after meals. Drink plenty of water through the day, because dehydration makes both nausea and constipation worse. Sip it between meals rather than drinking a lot with food, since extra liquid adds volume to a stomach that’s already slow to empty. If constipation is your main problem, you can add fermentable fibers gradually from foods like cooked veggies, berries, and legumes if you tolerate them, rather than starting a large dose of fiber supplement all at once, which can often exacerbate gas, bloating, and even make constipation worse. Talk to your prescriber about the pace of dose increases too, since side effects tend to flare with each step up. If you have severe or persistent vomiting, intense abdominal pain, or you can’t keep fluids down, call your doctor right away rather than trying to push through it.
There’s also the question of the gut microbiome. A 2025 review in Nutrients pulled together 38 animal and human studies and found that GLP-1 drugs do change the gut bacteria, but the results were inconsistent. Some studies of liraglutide, an older drug in this class, found increases in beneficial bacteria, while some studies of semaglutide found decreases in microbial diversity. My read is we don’t yet know how much the drugs themselves reshape the microbiome. We do know that eating far less fiber and fewer plant foods will change it, and that part’s within your control.
Muscle loss is the cost that gets way too little attention. Whenever you lose weight, some of what you lose is lean mass rather than fat. That’s true with dieting, bariatric surgery, and with these drugs. A 2024 review in Diabetes, Obesity, and Metabolism looked at body composition data from GLP-1 trials and found a wide range. In some studies, lean mass accounted for 40 to 60 percent of the weight lost, while in others it was about 15 percent or less. Results vary widely from study to study and from person to person, and we need to be careful about the headlines. Lean mass is not the same thing as muscle, since it also includes water, organs, and other tissue that isn’t fat. The authors of that review argued that some of the change looks like an appropriate adjustment to carrying less weight. I think that’s a fair point, and it’s one reason I don’t want to exaggerate this problem. Even so, I’d rather you not lose muscle you don’t need to lose, especially if you’re over 50 or a woman approaching or past menopause. Muscle is what lets you climb stairs, carry groceries, get up off the floor, and recover from an illness or injury. It’s also one of the main places your body stores and uses glucose. Most people already lose muscle as they age, and adding a large, fast weight loss on top of that isn’t a good combo. If you notice you’re getting weaker in the gym or everyday tasks feel harder even though you weigh less, take that as a sign to increase your training or your protein.
Bones are part of this too. A 2024 analysis in JAMA Network Open came from a trial in which people first lost weight on a low-calorie diet and were then assigned to exercise, to the GLP-1 drug liraglutide, to both, or to placebo. Compared with the exercise group, bone density at the hip and spine decreased in the group that took liraglutide alone. In the group that did both, bone density was no different from placebo, even though that group lost the most weight. The main results of that trial, in a 2021 paper in New England Journal of Medicine, showed people who combined liraglutide with regular exercise had about twice the drop in body fat percentage as people who did either one alone, and only the combination group improved insulin sensitivity and cardiorespiratory fitness. Liraglutide is less potent than semaglutide or tirzepatide, so I wouldn’t assume those numbers carry over exactly, but the direction fits what we know about exercise and weight loss.
This episode of Revolution Health Radio breaks down the research behind GLP-1 side effects and shares practical strategies to protect your health while taking them. Discover why protein, resistance training, nutrient-dense foods, and smart supplementation matter—and how to build healthy habits that last beyond the medication. #ChrisKresser #GLP-1
Resistance training comes first. Lift weights, use resistant bands, or do bodyweight exercises at least three times a week. Work all the major muscle groups and make the work gradually harder over time. Walking is great for many reasons, but on its own it isn’t a strong enough signal to hold on to muscle while you’re eating much less.
Protein is also critical. A 2018 meta-analysis from British Journal of Sports Medicine pooled almost 50 trials and found the benefit of protein for building muscle with resistance training leveled off at about 1.6 grams per kilogram of body weight per day, which is roughly 0.7 grams per pound. Those trials weren’t done in people eating in a large calorie deficit, and there’s reason to think you need at least that much when you’re losing weight. In a 2016 trial, young men who ate about 40 percent fewer calories than they needed and trained six days a week gained about a kilogram of lean mass eating 2.4 grams of protein per kilogram, while those eating half that amount gained almost none. That was a short study in young men, so it won’t translate directly to a 55-year-old on semaglutide, but the principle holds. It’s hard to eat enough protein, though, when you’re barely hungry. The most reliable approach is to eat the protein on your plate first, so it doesn’t get crowded out when you fill up. Aim for a solid serving at every meal– eggs, fish, meat, poultry, Greek yogurt, or cottage cheese if you tolerate dairy, and use a protein shake on days when you can’t face a full meal or when you need to boost your protein intake further. Creatine is a third tool worth considering. It’s one of the most studied supplements there is, and it’s inexpensive. A 2017 meta-analysis of 22 trials in older adults found people who took creatine while doing resistance training gained about 1.4 kilograms more lean tissue than people who did the training alone, and they got stronger, too. Some of that gain is water held in the muscle, and none of those trials included people taking GLP-1s. Still, it’s a low-risk addition for most people. If you have kidney disease, make sure to check with your doctor first.
Micronutrients are next, and they are easy to overlook because shortfalls rarely cause obvious symptoms, at least at first. If you eat 30 percent less food, you get about 30 percent less of the vitamins and minerals in it, unless you change what you eat. Many people are already falling short on nutrients like magnesium and vitamin D before they started the medication and cut their calorie intake. A 2025 cross-sectional study in Frontiers in Nutrition had 69 people taking GLP-1 drugs keep detailed three-day food records. Average intake fell below recommended levels for fiber, calcium, iron, magnesium, potassium, choline, and vitamins A, C, D, and E. Fiber averaged about 14 and a half grams per day, roughly half the usual recommendation, and vitamin D from food averaged four micrograms, about a quarter of the recommended amount. Protein looked adequate as a percentage of calories, but fell short when measured against body weight. Keep in mind that the recommended intakes for these nutrients is already too low, in my opinion. It was designed to be the amount that would help us avoid acute deficiency syndromes, not to promote optimal health. So, if these people were falling short of even these inadequate recommended levels, then they are way short of what I would consider to be the optimal levels of these nutrients.
A much larger 2025 study in Obesity Pillars used insurance claims data on more than 460,000 adults taking GLP-1s, most of whom had type 2 diabetes. About 22 percent were diagnosed with a nutritional deficiency within the first year, and vitamin D deficiency was the most common. That’s probably an undercount. People who saw a dietitian were more likely to be diagnosed, which suggests many deficiencies go unnoticed because nobody looks for them. Start by choosing the foods that deliver the most nutrition per bite. When your appetite is small, there isn’t room for foods that bring calories and little else. So prioritize shellfish and oily fish, eggs, red meat and poultry, organ meats like liver if you’re willing, and a variety of colorful vegetables and fruits. Get tested if you can. Ask your doctor to check vitamin D, B12, and iron status, including ferritin, before you start and periodically while you’re on the medication. The joint advisory I mentioned earlier recommends a thorough assessment before you start and ongoing steps to prevent nutrient deficiencies. Iron is one nutrient I’d never supplement without testing first because too much of it causes its own set of problems.
Then there are the changes to the face, skin, and hair, which many people feel most self-conscious about. “Ozempic face” isn’t a medical diagnosis, per se, but it describes something real. Hollowed cheeks, deeper lines, and looser skin around the jaw and neck after rapid weight loss. A 2023 commentary in Facial Plastic Surgery attributed it to the rapid loss of fat in the face, which leaves less volume under the skin. When weight comes off quickly, your skin has less time to adjust to the smaller volume underneath it. A 2025 review in the journal Endocrine went further and proposed that GLP-1 drugs might also affect skin aging directly through receptors on stem cells in fat tissue and on fibroblasts, the cells that make collagen. But I want to be careful with this finding. It’s a hypothesis based on laboratory and animal research, not something that’s been shown in people yet. And the same review noted these drugs could also have some benefits for skin. So this is worth watching, but it’s definitely not settled.
Hair shedding is another common complaint. A 2025 scoping review noted more than a thousand reports of hair loss with these drugs in the FDA’s adverse event reporting system. Most of these studies it included didn’t have a dermatologist confirm the diagnosis, and the one study that described the pattern found mostly telogen effluvium and androgenetic hair loss. Telogen effluvium is a type of diffuse shedding that can follow any rapid weight loss, major physical stress, or drop in protein intake. The authors couldn’t confirm that the drugs cause it, and they raised the possibility that drugs may just be altering the hair growth cycle. My view is that for most people, the rapid weight loss is the most likely trigger, as well as the reduction in protein intake, and this kind of shedding usually settles down once the underlying stress does.
The strategies here overlap with everything else we’ve covered. Avoid sunburn or excessive sun exposure, don’t smoke, get enough sleep, since UV exposure, smoking, and poor sleep all speed up skin aging. It’s also reasonable to ask your prescriber about increasing your dose more slowly, because the speed of weight loss seems to be a big part of the problem. Timing matters too. If you’re about to start one of these medications or you’re in the first few months, this is the best time to set things up. Before the weight starts coming off, get a baseline. The joint advisory recommends assessing muscle strength, physical function, and body composition before therapy begins, and I’d add the labs that we talked about earlier. The baseline could be a DEXA scan, or something as simple as recording how many times you get up from a chair in 30 seconds, how much you can lift for a set of 10, and your waist measurement. Repeat those measures every few months. They show whether you’re losing fat or muscle, which the scale can’t tell you.
Next, build the habits while the medication makes them easier. Many people say their food cravings drop sharply on these drugs, and that gives you room to set up a strength training routine, learn to cook a few protein-rich meals you like, and get used to eating mostly whole foods. These habits are much harder to build from scratch once your appetite returns. Finally, go in with a plan for the long term. The regain data from the STEP 1 extension and SURMOUNT-4 suggest that for many people, the benefits of these drugs last only as long as they keep taking them. Some will decide to stay on a GLP-1 indefinitely, some will taper to a lower dose with their prescriber’s help, and some will stop. Whichever path you choose, the muscle you’ve preserved and the habits you built are what stay with you.
Like what you’re reading? Get my free newsletter, recipes, eBooks, product recommendations, and more!
Now let’s talk about supplements. None of these are a substitute for medical care, of course, and if you’re having significant side effects, that’s a conversation for your prescriber. What supplements can do is help fill nutritional gaps that are much harder to close with food when you’re eating a lot less. Beyond the creatine I mentioned earlier, here are three I’d consider, all formulas I developed at Adapt Naturals. The first is a multivitamin, because it covers the most ground, and Bio-Avail Multi is the one I formulated. It uses active forms of several B vitamins, including folate as methylfolate and 200 micrograms of B12 as methylcobalamin. It has 3,000 IU vitamin D3, both K1 and K2, and magnesium and zinc as bisglycinate chelates, meaning they’re bound to the amino acid glycine and they are better absorbed. It doesn’t contain iron, which I think is the right call for the reason I gave earlier. It also doesn’t contain calcium, so foods like dairy, sardines with bones, and leafy greens still matter. It’s designed to support healthy nutrient levels and energy when your diet can’t cover everything. The daily serving is four capsules split between two meals, and taking them with food, even a small meal, is usually easier on the stomach.
The second is Biome Protect, a gut health formula that’s especially relevant when you’re eating less fiber and fewer plant foods than you used to. It has four parts. The first part is a spore-forming probiotic, Bacillus coagulans, in a strain that survives stomach acid. In a 2023 randomized trial in the journal Medicine, otherwise healthy adults with regular gas and bloating who took that strain at the same dose that’s in the formula had better digestive symptom scores than people on placebo after four weeks. The second is tributyrin, a form of butyrate, the short-chain fatty acid your gut bacteria make from fiber and the cells lining your colon use as their main fuel. The third is a bacteriophage prebiotic, used at just 15 milligrams, so it adds almost no bulk compared with the several grams typical of fiber-based prebiotics. The fourth is a blend of polyphenols from pomegranate, grape seed, blueberry, and cranberry. The formula is designed to support digestive comfort and a healthy gut microbiome.
The third is Inner Radiance, which I formulated to support skin from the inside. Vitamin C is required for your body to make collagen. Hyaluronic acid, which helps skin hold on to water, is included at 120 milligrams, the same dose used in a 2021 randomized trial in Nutrients that found improvements in skin moisture, elasticity, and the appearance of wrinkles over 12 weeks. Lutein and zeaxanthin are included at 10 and 2 milligrams, respectively. The same amounts were used in a 2016 trial that found improvements in skin tone and luminance. It also contains eggshell membrane, a natural source of collagen and other connective tissue proteins, rice ceramides to support the skin’s moisture barrier, and biotin. It’s designed to support skin hydration and elasticity. It’s not magic. It won’t replace facial volume that’s been lost with weight loss, and I don’t want to suggest otherwise. But it can improve several aspects of skin health, including glow, which many people complain about losing with Ozempic. So it’s worth a try. Keep in mind that biotin, which is in this product, can interfere with some lab tests, so if you’re getting blood work done, stop it for a few days before the blood test, or talk to your doctor about it. Whatever supplements you consider, run them by the person who prescribes your medication, especially if you have a chronic health condition or take drugs.
When people talk about these medications, the question is usually whether you should take one. For the millions of people who already do, the more useful question is what the drug changes about everything else. With less food coming in, the quality of each meal and the demands you place on your muscles matter more than they did before. Many people start these drugs expecting the hard part to be over, when in some ways the work has just changed. A GLP-1 makes eating less much easier. It doesn’t choose your food or do your strength training for you. Those choices are still yours, and they shape how you look and feel long after the weight comes off.
Thanks for listening. You can find the show notes and links to all the studies I mentioned at ChrisKresser.com. If you have questions about this episode or suggestions for future topics, head over to ChrisKresser.com/podcastquestion and leave me a message. I read all of them, and your questions help shape the content I create. Until next time, be well.
Better supplementation. Fewer supplements.
Close the nutrient gap to feel and perform your best.
A daily stack of supplements designed to meet your most critical needs.

